Janney Montgomery Scott
LGND icon

Janney Montgomery Scott’s Ligand Pharmaceuticals LGND Stock Holding History

Janney Montgomery Scott’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-46,756
Closed -$3.96M – 2047
2018
Q4 		$3.96M Sell
46,756
-1,400
-3% -$149K 0.04% 422
2018
Q3 		$8.25M Sell
48,156
-601
-1% -$90.6K 0.07% 294
2018
Q2 		$6.3M Buy
48,757
+5,080
+12% +$567K 0.06% 324
2018
Q1 		$4.5M Sell
43,677
-657
-1% -$65K 0.05% 400
2017
Q4 		$3.79M Sell
44,334
-1,077
-2% -$93.3K 0.04% 438
2017
Q3 		$3.86M Buy
+45,411
New +$3.6M 0.04% 406
2017
Q2 		– Sell
-3,929
Closed -$259K – 1781
2017
Q1 		$259K Sell
3,929
-1,125
-22% -$74K ﹤0.01% 1481
2016
Q4 		$320K Buy
5,054
+1,407
+39% +$88.8K ﹤0.01% 1291
2016
Q3 		$232K Buy
+3,647
New +$268K ﹤0.01% 1319
2015
Q3 		– Sell
-3,429
Closed -$216K – 1429
2015
Q2 		$216K Buy
+3,429
New +$187K ﹤0.01% 1737

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Janney Montgomery Scott's LGND Position: Q1 2019 in Review

Janney Montgomery Scott sold out of Ligand Pharmaceuticals (LGND) in Q1 2019, closing a stake of 46,756 shares — an estimated $3.96M sold.

Janney Montgomery Scott first reported a position in LGND in Q2 2015 and held it in 10 quarters. The position peaked at $8.25M in Q3 2018. 330 funds tracked by Wall St. Rank hold LGND as of Q1 2019.

  • Janney Montgomery Scott reported no remaining Ligand Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Janney Montgomery Scott sold 46,756 Ligand Pharmaceuticals shares in Q1 2019, an estimated $3.96M.
  • Janney Montgomery Scott first reported a position in Ligand Pharmaceuticals in Q2 2015 and held it in 10 quarters.
  • Janney Montgomery Scott's Ligand Pharmaceuticals position peaked at $8.25M in Q3 2018.
  • 330 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2019.

Based on Janney Montgomery Scott's 13F filing for Q1 2019, filed 30 Apr 2019.